A-B) U2OS cells synchronized in G2 phase 7.5 h after thymidine release were treated with 1 Gy IR. The number of phospho-ATM foci (A) and number of γH2AX foci (B) at different timepoints after IR treatment are shown (mean ± S.D. (n=2)). C) From data obtained in A and B, the number of γH2AX foci and phospho-ATM foci were plotted against each other. They showed a linear correlation (R 2 = 0.94). D) FACS staining for phospho-histone H3 and DNA content shows that 79% of U2OS cells in the population are in the G2 phase 7.5 h after thymidine release. E) Confocal image of immunofluorescence staining against γH2AX and phospho-histone H3 in cells that recovered from G2 and entered mitosis, with or without exposure to DNA damage. Scale bar: 10 µm. F) Asynchronous U2OS cells were treated with nocodazole for up to 12 h. The bar chart shows the mean γH2AX foci number ± SEM. in mitotic cells at different time-points after nocodazole treatment (n=3). G) Asynchronous U2OS cells were pulsed with 10 µM etoposide for different durations. One hour after the etoposide pulse, cells were stained for γH2AX. The graph shows the number of γH2AX foci plotted against the duration of the etoposide pulse. H) Asynchronous U2OS cells were treated with different doses of IR. One hour after, cells were stained for γH2AX. The graph shows the number of γH2AX foci plotted against the IR dose. I) RPE1 cells treated as in Figure 1F -G. Briefly, G2-synchronized cells were either exposed to IR or left untreated; 3 h later, the cells were treated with colchicine for 1.5 h before preparation of metaphase spreads and DAPI Staining. Panels show representative cells that entered metaphase without or with IR treatment, with the inset panel enlarging a damaged chromosome. The bar chart depicts the mean number of metaphase breaks ± S.D. (in each condition, n>60). J) FACS staining for phospho-histone H3 and DNA content shows that 83% of RPE1 cells in the population were in the G2 phase 6 h after thymidine release. 
A) Lysates from parental U2OS cells, or cells harbouring the integrated PLK1 FRET sensor and MDC1-mCherry, were blotted with antibodies against mCherry, MDC1 or Hsp90 (used as a loading control). * signifies a cross-reacting band. B) U2OS cells harbouring the integrated PLK1 FRET sensor and MDC1-mCherry were either treated with 3 Gy IR, or left untreated, and subsequently stained with antibody against γH2AX. Confocal images were taken. The exogenously expressed MDC1-mCherry forms damageinduced foci co-localizing with γH2AX foci. C) Lysates were prepared from U2OS cells harbouring the integrated PLK1 FRET sensor treated with thymidine (Thy), taxol (Tax), and after release from thymidine arrest for 7 h (7h p.r.) or 8.5 h (8.5 h p.r.) in the presence (+) or absence (-) of the PLK1 inhibitor, BI2536. The top panel depicts immunoprecipitates prepared from the lysates with anti-GFP antibody to pull down the PLK1 FRET sensor protein, subsequently probed with an anti-pThr specific antibody to show sensor modification. * marks a non-specific band. The lower two panels show blots of the lysates probed with anti-phospho-(p)Myt1 (with anti-Myt1 as a control) or anti-phospho-(p)PLK1 (with anti-PLK1 as a control). The final lane (PP) shows the taxol-treated sample after treatment with phosphatase. D) U2OS cells carrying the integrated PLK1 FRET sensor were monitored during the cell cycle by live-cell imaging. The graph shows the average trajectory of the relative PLK1 activity (FRET index change) in asynchronous cells traversing G2 and mitotic cell division (mean ± SEM, n=6). Plots were aligned to the time of maximal PLK1 activity.
Supplementary Figure 3: Response of U2OS cell lines with integrated PLK1 FRET sensor and MDC1-mCherry to DNA damage.
A) Remaining level of checkpoint activation signal (MDC1 foci number) and initial level of checkpoint activation signal were extracted from experimental measurement in Figure 3 . They were plotted against each other in this graph. Statistical analysis shows there is a non-zero correlation between the remaining level of checkpoint activation signal (MDC1 foci number) and initial level of checkpoint activation signal (slope of correlation significantly different from zero, F test, p=0.008). B) shows the level of checkpoint activation signal (MDC1 foci number) monitored by live-cell imaging in the following conditions: remaining foci level at mitotic entry in undamaged U2OS cells (Undamaged (foci at mitotic entry)); remaining foci level at mitotic entry in cells exposed to DNA damage (Damaged (foci at mitotic entry)); remaining foci number in cells that still arrest in G2 24 h after exposure to DNA damage (Damaged (foci in G2 cells)) or remaining foci number in cells that were treated with BI2536 and remain arrested in the G2 phase 24 h after damage (Damaged+BI2536 (foci in G2 cells)). C) U2OS cells were treated as in Figure 3 . While Figure 3C The results shown here compare the plots of raw PLK1 activity (top) and relative PLK1 activity after standardization (below) from two experiments using precisely the same setup but carried out on two different days. Thus, the medians of the raw starting FRET values vary from 0.83 (experiment 1) to 0.844 (experiment 2. The medians from both experiments were standardized to the same level (arbitrarily set to a value of "0") as described in Supplementary methods. This method standardization preserved the heterogeneity of the starting FRET values within and between experiments and did not affect the trend of the curve.
Supplementary Figure 4:
Relative PLK1 activity in RPE1 cells after DNA damage in G2. A) RPE1 cells carrying an integrated PLK1 sensor were released from thymidine block for 6 h and tracked by live-cell imaging. The relative PLK1 activity was plotted over time until just before NEBD at mitotic entry. The coloured lines represent individual cells (n=20). B) RPE1 cells released from thymidine block for 6 h were treated with 1 Gy IR and tracked by live cell imaging. The relative PLK1 activity was plotted overtime until just before NEBD at mitotic entry. The coloured lines represent individual cell (n=42). C) Measurements from A-B) were extracted and for single cells, cumulative PLK1 activity at mitotic entry (change in the FRET index from the baseline) with or without damage exposure were compared. The mean values of cumulative PLK1 activity do not differ significantly with or without damage exposure (unpaired t-test, p=0.7).
